Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib (vol 24, pg 917, 2019)

被引：0
|
作者：
Tamura, Kazuo [1 ]
Nukiwa, Toshihiro [2 ]
Gemma, Akihiko [3 ]
Yamamoto, Nobuyuki [4 ]
Mizushima, Masaya [5 ]
Ochai, Kaori [6 ]
Ikeda, Rie [7 ]
Azuma, Hisaya [5 ]
Nakanishi, Yoichi [8 ]
机构：
[1] Fukuoka Univ, Sch Med, Gen Med Res Ctr, Fukuoka, Fukuoka, Japan
[2] Tohoku Univ, Sendai, Miyagi, Japan
[3] Nippon Med Sch, Tokyo, Japan
[4] Wakayama Med Univ, Dept Internal Med 3, Div Pulmonol & Med Oncol, Wakayama, Japan
[5] Nippon Boehringer Ingelheim Co Ltd, Med Div, Special Care Med, Tokyo, Japan
[6] EPS Corp, Stat Anal Dept 2, PMS Div, Tokyo, Japan
[7] Nippon Boehringer Ingelheim Co Ltd, Pharmacovigilance, Post Mkt Surveillance Grp, Tokyo, Japan
[8] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Fukuoka, Japan
来源：
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 24卷 / 09期
关键词：
D O I：
10.1007/s10147-019-01488-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The original article can be found online.
引用
收藏
页码：1169 / 1169
页数：1
相关论文
共 50 条
  • [1] Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
    Kazuo Tamura
    Toshihiro Nukiwa
    Akihiko Gemma
    Nobuyuki Yamamoto
    Masaya Mizushima
    Kaori Ochai
    Rie Ikeda
    Hisaya Azuma
    Yoichi Nakanishi
    [J]. International Journal of Clinical Oncology, 2019, 24 : 917 - 926
  • [2] Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
    Tamura, Kazuo
    Nukiwa, Toshihiro
    Gemma, Akihiko
    Yamamoto, Nobuyuki
    Mizushima, Masaya
    Ochai, Kaori
    Ikeda, Rie
    Azuma, Hisaya
    Nakanishi, Yoichi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (08) : 917 - 926
  • [3] Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
    Kazuo Tamura
    Toshihiro Nukiwa
    Akihiko Gemma
    Nobuyuki Yamamoto
    Masaya Mizushima
    Kaori Ochai
    Rie Ikeda
    Hisaya Azuma
    Yoichi Nakanishi
    [J]. International Journal of Clinical Oncology, 2019, 24 : 1169 - 1169
  • [4] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
    Watanabe, Satomi
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [5] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer
    Satoshi Igawa
    Taihei Ono
    Masashi Kasajima
    Seiichiro Kusuhara
    Sakiko Otani
    Tomoya Fukui
    Masanori Yokoba
    Masaru Kubota
    Masato Katagiri
    Hisashi Mitsufuji
    Jiichiro Sasaki
    Katsuhiko Naoki
    [J]. Investigational New Drugs, 2020, 38 : 1906 - 1914
  • [6] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer
    Igawa, Satoshi
    Ono, Taihei
    Kasajima, Masashi
    Kusuhara, Seiichiro
    Otani, Sakiko
    Fukui, Tomoya
    Yokoba, Masanori
    Kubota, Masaru
    Katagiri, Masato
    Mitsufuji, Hisashi
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1906 - 1914
  • [7] Impact of afatinib dosing on safety and efficacy in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC) in a real-world setting
    Halmos, Balazs
    Tan, Eng-Huat
    Soo, Ross
    Cadranel, Jacques
    Lee, Min Ki
    Foucher, Pascal
    Hsia, Te-Chun
    Hochmair, Maximilian
    Griesinger, Frank
    Hida, Toyoaki
    Kim, Edward
    Melosky, Barbara
    Maerten, Angela
    Carcereny, Enric
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 160 - 161
  • [8] Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
    Lee, Sung Yong
    Choi, Chang-Min
    Chang, Yoon Soo
    Lee, Kye Young
    Kim, Seung Joon
    Yang, Sei Hoon
    Ryu, Jeong Seon
    Lee, Jeong Eun
    Lee, Shin Yup
    Park, Ji Young
    Kim, Young-Chul
    Oh, In-Jae
    Jung, Chi Young
    Lee, Sang Hoon
    Yoon, Seong Hoon
    Choi, Juwhan
    Jang, Tae Won
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) : 4353 - +
  • [9] First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting
    Park, Keunchil
    Lim, Darren Wan-Teck
    Okamoto, Isamu
    Yang, James Chih-Hsin
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [10] Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
    Alsharedi, M.
    Bukamur, H.
    Elhamdani, A.
    [J]. DRUGS OF TODAY, 2018, 54 (06) : 369 - 379
12345